Yahoo Web Search

Search results

      • Mylan is the final stages of its megamerger with Pfizer's Upjohn unit, a deal that will reshape the global generics market if it passes regulatory scrutiny. For Mylan CEO Heather Bresch, the deal wrapup means she'll be out of a job after nearly three decades at the company––but at least she'll go out with a big raise.
  1. People also ask

  2. On September 7, 2021, Ryan Grim of The Intercept reported that during an ongoing racketeering case involving Mylan and Bresch, "newly released court documents show [Bresch] discussing a deal with Pfizer to eliminate a chief competitor to EpiPen, clearing the way for major price hikes."

  3. Jul 29, 2019 · Mylan’s current chairman, Robert Coury, will be its executive chairman and Upjohn’s current president, Michael Goettler, will be the CEO. Mylan’s current CEO, Heather Bresch, will retire ...

  4. Oct 29, 2019 · Some six weeks after that, on June 14, Coury and Mylan CEO Heather Bresch met up with Bourla and his CFO, Frank D’Amelio, in New York. There, in Pfizer's home city, they ironed out a...

    • Angus Liu
  5. Jul 29, 2019 · Mylan CEO Heather Bresch will retire after the deal closes and its Chairman Robert Coury will be the executive chairman of the new company. Mylan shares jumped 20% to $22.10, while...

  6. Jul 29, 2019 · DJIA. +0.80% Mylan N.V. myl said that in connection with the deal to merge with Pfizer Inc.'s PFE, +0.04% Upjohn business announced Monday, Chief Executive Heather Bresch will retire, after...

    • tkilgore@marketwatch.com
  7. Jul 29, 2019 · Mylan CEO Heather Bresch will retire after the deal closes and its Chairman Robert Coury will be the executive chairman of the new company.

  8. Jul 29, 2019 · Global pharmaceutical company Mylan NV announced its CEO and Board Director Heather Bresch will retire as the company merges with Pfizer Inc. unit Upjohn by the middle of 2020 to form a...

  1. People also search for